Fagbule OF. Novel coronavirus. Ann Ib Postgrad Med. 2019;2019(17):108–10.
Google Scholar
Du Toit A. Outbreak of a novel coronavirus. Nat Rev Microbiol. 2020;18:123.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470–3.
CAS
PubMed
PubMed Central
Google Scholar
Xu YH, Dong JH, An WM, Lv XY, Yin XP, Zhang JZ, et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect. 2020;80:394–400.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: an overview. J Chin Med Assoc. 2020;83:217–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Park SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Clin Exp Pediatr. 2020;63:119–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sun Y, Koh V, Marimuthu K, Ng OT, Young B, Vasoo S, et al. Epidemiological and clinical predictors of COVID-19. Clin Infect Dis. 2020;71:786–92.
Article
CAS
PubMed
Google Scholar
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
Article
CAS
PubMed
PubMed Central
Google Scholar
Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a novel SARS-CoV-2. Gene Reports. 2020;19:100682.
Article
PubMed
PubMed Central
Google Scholar
Astuti I, Yasrafil A. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Diabetes Metabol Syndr. 2020;14:407–4012.
Article
Google Scholar
Zhang G, Zhang J, Wang B, Zhu X, Wang Q, Qiu S. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Respir Res. 2020;21:s12931.
Google Scholar
Phan T. Novel coronavirus: from discovery to clinical diagnostics. Infect Genet Evol. 2020;79:104211.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11:1–12.
Google Scholar
Bianchi M, Benvenuto D, Giovanetti M, Angeletti S, Ciccozzi M, Pascarella S. Sars-CoV-2 envelope and membrane proteins: structural differences linked to virus characteristics? BioMed Res Int. 2020;2020:78.
Article
CAS
Google Scholar
Zeng W, Liu G, Ma H, Zhao D, Yang Y, Liu M, Mohammed A, Zhao C, Yang Y, Xie J, Ding C. Biochemical characterization of SARS-CoV-2 nucleocapsid protein. Biochem Biophys Res Commun. 2020;527:618–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Alanagreh LA, Alzoughool F, Atoum M. The human coronavirus disease COVID-19: its origin, characteristics, and insights into potential drugs and its mechanisms. Pathogens. 2020;9:331.
Article
CAS
PubMed Central
Google Scholar
Cong Y, Ulasli M, Schepers H, Mauthe M, V’kovski P, Kriegenburg F, et al. Nucleocapsid protein recruitment to replication-transcription complexes plays a crucial role in coronaviral life cycle. J Virol. 2020;94:e01925.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gibson CA, Schlesinger JJ, Barrett AD. Prospects for a virus non-structural protein as a subunit vaccine. Vaccine. 1988;6:7–9.
Article
CAS
PubMed
Google Scholar
Ip PP, Boerma A, Regts J, Meijerhof T, Wilschut J, Nijman HW, Daemen T. Alphavirus-based vaccines encoding nonstructural proteins of hepatitis C virus induce robust and protective T-cell responses. Mol Ther. 2014;22:881–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ludert JE, Reyes-Sandoval A. The dual role of the antibody response against the flavivirus non-structural protein 1 (NS1) in protection and immunopathogenesis. Front Immunol. 2019;10:1651.
Article
PubMed
PubMed Central
CAS
Google Scholar
Henriques HR, Rampazo EV, Gonçalves AJ, Vicentin EC, Amorim JH, Panatieri RH, et al. Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge. PLoS Negl Trop Dis. 2013;7:e2330.
Article
PubMed
PubMed Central
Google Scholar
Irini A, Doytchinova S, Darren RF. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinf. 2007;8:4.
Article
CAS
Google Scholar
Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinf. 2007;8:424.
Article
CAS
Google Scholar
Gupta C, et al. In silico approach for predicting toxicity of peptides and proteins. PLoS ONE. 2013;8(9):e73957.
Article
CAS
PubMed
PubMed Central
Google Scholar
Calis JJA, Maybeno M, Greenbaum JA, Weiskopf D, De Silva AD, Sette A, et al. Properties of MHC class I presented peptides that enhance immunogenicity. PloS Comp Biol. 2013;9:e1003266.
Article
Google Scholar
Jensen KK, Andreatta M, Marcatili P, Buus S, Greenbaum JA, Yan Z, et al. Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology. 2018;154:394–406.
Article
CAS
PubMed
PubMed Central
Google Scholar
Saha S, Raghava GP. AlgPred: prediction of allergenic proteins and mapping of IgE epitopes. Nucleic Acids Res. 2006;34:202–9.
Article
CAS
Google Scholar
Dhanda SK, Vir P, Raghava GP. Designing of interferon-gamma inducing MHC class-II binders. Biol Direct. 2013;8:30.
Article
PubMed
PubMed Central
CAS
Google Scholar
Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinf. 2006;7:1–5.
Article
CAS
Google Scholar
Larsen JE, Lund O, Nielsen M. Improved method for predicting linear B-cell epitopes. Immunome Res. 2006;2:1–7.
Article
CAS
Google Scholar
Emini EA, Hughes JV, Perlow D, Boger J. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol. 1985;55:836–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kolaskar AS, Tongaonkar PC. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 1990;276:172–4.
Article
CAS
PubMed
Google Scholar
Bandyopadhyay A, Cambray S, Gao J. Fast and selective labeling of N-terminal cysteines at neutral pH via thiazolidino boronate formation. Chem Sci. 2016;7:4589–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jin J, Hjerrild KA, Silk SE, Brown RE, Labbé GM, Marshall JM, et al. Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal ‘C-tag.’ Int J Parasitol. 2017;47:435–46.
Gasteiger E, Hoogland C, Gattiker A, Wilkins MR, Appel RD, Bairoch A. Protein identification and analysis tools on the ExPASy server. The proteomics protocols handbook. Totowa: Humana press; 2005. p. 571–607.
Book
Google Scholar
Jones DT. Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol. 1999;292:195–202.
Article
CAS
PubMed
Google Scholar
Yang J, Anishchenko I, Park H, Peng Z, Ovchinnikov S, Baker D. Improved protein structure prediction using predicted interresidue orientations. Proc Natl Acad Sci. 2020;117:1496–503.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sippl MJ. Recognition of errors in three-dimensional structures of proteins. Proteins. 1993;17:355–62.
Article
CAS
PubMed
Google Scholar
Prisant MG, Richardson JS, Richardson DC. Structure validation by Calpha geometry: Phi, psi and Cbeta deviation. Proteins. 2003;50:437–50.
Article
PubMed
CAS
Google Scholar
Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 1993;2:1511–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tovchigrechko A, Vakser IA. Development and testing of an automated approach to protein docking. Proteins. 2005;60:296–301.
Article
CAS
PubMed
Google Scholar
Rapin N, Lund O, Bernaschi M, Castiglione F. Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS One. 2010;5:e9862.
Article
PubMed
PubMed Central
CAS
Google Scholar
Grote A, Hiller K, Scheer M, Münch R, Nörtemann B, Hempel DC, Jahn D. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 2005;33:W526–31.
Article
CAS
PubMed
PubMed Central
Google Scholar
Besmer E, Market E, Papavasiliou FN. The transcription elongation complex directs activation-induced cytidine deaminase-mediated DNA deamination. Mol Cell Biol. 2006;26:4378–85.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rapin N, Lund O, Castiglione F. Immune system simulation online. Bioinformatics. 2011;27:2013–4.
Article
CAS
PubMed
Google Scholar
Bar-On YM, Flamholz A, Phillips R, Milo R. Science Forum: SARS-CoV-2 (COVID-19) by the numbers. Elife. 2020;9:e57309.
Article
PubMed
PubMed Central
Google Scholar
Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus Disease 2019 – COVID-19. Clin Microbiol Rev. 2020;33:e00028-e120.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tobaiqy M, Qashqary M, Al-Dahery S, Mujallad A, Hershan AA, Kamal MA, et al. Therapeutic management of patients with COVID-19: a systematic review. Infect Prev Pract. 2020;2:100061.
Article
PubMed
PubMed Central
Google Scholar
Kaur R, Arora N, Jamakhani MA, Malik S, Kumar P, Anjum F, et al. Development of multi-epitope chimeric vaccine against Taenia solium by exploring its proteome: an in silico approach. Expert Rev Vaccines. 2020;19:105–14.
Article
CAS
PubMed
Google Scholar
Amawi H, Abu Deiab GA, Aljabali AA, Dua K, Tambuwala MM. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Therapeutic Delivery. 2020;11:245–68.
Article
CAS
PubMed
Google Scholar
Ahmed SF, Quadeer AA, McKay MR. Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses. 2020;12:254.
Article
CAS
PubMed Central
Google Scholar
Wang J, Wen J, Li J, Yin J, Zhu Q, Wang H, et al. Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus. Clin Chem. 2003;49:1989–96.
Article
CAS
PubMed
PubMed Central
Google Scholar
Saadi M, Karkhah A, Nouri HR. Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches. Infect Genet Evol. 2017;51:227–34.
Article
CAS
PubMed
Google Scholar
Singh A, Thakur M, Sharma LK, Chandra K. Designing a multi-epitope peptide based vaccine against SARS-CoV-2. Sci Rep. 2020;10(1):1–2.
Article
CAS
Google Scholar
Dong R, Chu Z, Yu F, Zha Y. Contriving multi-epitope subunit of vaccine for COVID-19: immunoinformatics approaches. Front Immunol. 2020;28(11):1784.
Article
CAS
Google Scholar
Safavi A, Kefayat A, Mahdevar E, Abiri A, Ghahremani F. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Vaccine. 2020;38(48):7612–28.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen X, Zaro JL, Shen WC. Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev. 2013;65:1357–69.
Article
CAS
PubMed
Google Scholar
Nezafat N, Ghasemi Y, Javadi G, Khoshnoud MJ, Omidinia E. A novel multi-epitope peptide vaccine against cancer: an in silico approach. J Theor Biol. 2014;349:121–34.
Article
CAS
PubMed
Google Scholar
Livingston B, Crimi C, Newman M, Higashimoto Y, Appella E, Sidney J, et al. A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes. J Immunol. 2002;168:5499–506.
Article
CAS
PubMed
Google Scholar
Melief CJ, Van Der Burg SH. Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines. Nat Rev Cancer. 2008;8:351–60.
Article
CAS
PubMed
Google Scholar
Botos I, Segal DM, Davies DR. The structural biology of Toll-like receptors. Structure. 2011;19:447–59.
Article
CAS
PubMed
PubMed Central
Google Scholar
Droppa-Almeida D, Franceschi E, Padilha FF. Immune-informatic analysis and design of peptide vaccine from multi-epitopes against Corynebacterium pseudotuberculosis. Bioinform Biol Insights. 2018;12:1177932218755337.
Article
PubMed
PubMed Central
Google Scholar
Wise J. Covid-19: The E484K mutation and the risks it poses. BMJ. 2021;372:n359.
Article
PubMed
Google Scholar
Abu-Raddad LJ, Chemaitelly H, Butt AA; National Study Group for COVID-19 Vaccination. Effectiveness of the BNT162b2 Covid-19 Vaccine against the B1.1.7 and B.1.351 Variants. N Engl J Med. 2021. Doi: https://doi.org/10.1056/NEJMc2104974.
Madhi SA, Baillie V, Cutland CL, Voysey M, Koen AL, Fairlie L, Padayachee SD, Dheda K, Barnabas SL, Bhorat QE, Briner C. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant. N Engl J Med. 2021. https://doi.org/10.1056/NEJMoa2102214.
Article
PubMed
PubMed Central
Google Scholar
McCarthy KR, Rennick LJ, Nambulli S, Robinson-McCarthy LR, Bain WG, Haidar G, Duprex WP. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science. 2021;371(6534):1139–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang P, Nair MS, Liu L, Iketani S, Luo Y, Guo Y, Wang M, Yu J, Zhang B, Kwong PD, Graham BS. Antibody resistance of SARS-CoV-2 variants B. 1.351 and B. 1.1. 7. Nature. 2021;8:1–6.